Is Impel Pharmaceuticals Inc. (IMPL) a Buy, Sell, or Hold?
NASDAQ : IMPL
Impel Pharmaceuticals Inc. — Institutional Ownership
$0.04 USD
-$0.01 (-27.27%)
- Volume
- 720.03K
- Average Volume
- 1.05M
- Market Capitalization
- $956K
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $4.20
- Year Low
- $0.02
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.60
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2023-09-15 | Oaktree PRE Life Sciences Fund, L.P. | 114.04K | 0.45% |
| 2023-09-15 | Oaktree Capital Group, LLC | 127.38K | 0.51% |
| 2023-09-15 | Atlas OCM Holdings, LLC | 1.21M | 4.82% |
| 2023-09-15 | Oaktree-TCDRS Strategic Credit, LLC | 14641.0 | 0.06% |
| 2023-09-15 | Oaktree-TBMR Strategic Credit Fund F, LLC | 11155.0 | 0.04% |
| 2023-09-15 | INPRS Strategic Credit Holdings, LLC | 5424.0 | 0.02% |
| 2023-09-15 | Oaktree Diversified Income Fund Inc. | 26745.0 | 0.11% |
| 2023-09-15 | Oaktree LSL Fund Holdings EURRC S.à r.l. | 118.88K | 0.47% |
| 2023-09-15 | BAM Partners Trust | 127.38K | 0.51% |
| 2023-09-15 | Brookfield Asset Management ULC | 1.21M | 4.82% |
| 2023-09-15 | Oaktree LSL Fund Delaware Holdings EURRC, L.P. | 101.9K | 0.41% |
| 2023-09-15 | Brookfield Corporation | 127.38K | 0.51% |
| 2023-09-15 | Oaktree-Forrest Multi-Strategy, LLC | 11836.0 | 0.05% |
| 2023-09-15 | Oaktree-TBMR Strategic Credit Fund C, LLC | 7120.0 | 0.03% |
| 2023-09-15 | Oaktree-TBMR Strategic Credit Fund G, LLC | 18208.0 | 0.07% |
| 2023-09-15 | Oaktree-TSE 16 Strategic Credit, LLC | 18328.0 | 0.07% |
| 2023-09-15 | Oaktree Gilead Investment Fund AIF (Delaware), L.P. | 91735.0 | 0.37% |
| 2023-09-15 | Oaktree Specialty Lending Corporation | 350.24K | 1.40% |
| 2023-09-15 | Oaktree Strategic Credit Fund | 127.38K | 0.51% |
| 2023-09-15 | Oaktree GCP Fund Delaware Holdings, L.P. | 8149.0 | 0.03% |
| 2023-09-15 | Oaktree AZ Strategic Lending Fund, L.P. | 174.24K | 0.69% |
| 2023-09-15 | Oaktree Loan Acquisition Fund, L.P. | 135.86K | 0.54% |
| 2021-08-10 | 10) | 3.08M | 13.81% |
| 2021-08-10 | 10) | 3.08M | 13.81% |
| 2021-08-10 | 10) | 3.08M | 13.81% |
| 2021-08-10 | 10) | 3.08M | 13.81% |
| 2021-08-10 | 10) | 3.08M | 13.81% |
| 2021-08-10 | 13.81% | 3.08M | 13.81% |
| 2021-05-07 | KKR Health Care Strategic Growth Fund L.P. | 3.8M | 19.60% |
| 2021-05-07 | KKR Associates HCSG L.P. | 3.8M | 19.60% |
| 2021-05-07 | KKR HCSG GP LLC | 3.8M | 19.60% |
| 2021-05-07 | KKR Group Partnership L.P. | 3.8M | 19.60% |
| 2021-05-07 | KKR & Co. Inc. | 3.8M | 19.60% |
| 2021-05-07 | KKR Management LLP | 3.8M | 19.60% |
| 2021-05-07 | Henry R. Kravis | 3.8M | 19.60% |
| 2021-05-07 | George R. Roberts | 3.8M | 19.60% |
| 2021-05-07 | venBio Global Strategic GP II, Ltd. | 2.76M | 14.20% |
| 2021-05-07 | Robert Adelman | 2.76M | 14.20% |
| 2021-05-07 | Corey Goodman | 2.76M | 14.20% |
| 2021-05-07 | venBio Global Strategic Fund II, L.P. | 2.76M | 14.20% |
| 2021-05-07 | venBio Global Strategic GP II, L.P. | 2.76M | 14.20% |
| 2021-05-07 | KKR Iris Investors LLC | 3.8M | 19.60% |
| 2021-05-07 | KKR Group Holdings Corp. | 3.8M | 19.60% |
| 2021-05-06 | Vivo Capital VIII, LLC | 2.88M | 14.90% |
IMPL Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2022-12-31 | $3.75 | 23.45M | $87.92M | $60.65M | $51.19M | $78.45M |
| 2021-12-31 | $8.63 | 14.6M | $126M | $88.21M | $29.45M | $67.24M |
| 2020-12-31 | $15.00 | 13.14M | $197.08M | $7.1M | $8.41M | $198.4M |
| 2019-12-31 | $15.00 | 13.14M | $197.08M | $37M | -$ | $160.08M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2023-09-30 | $0.43 | 23.75M | $10.21M | $239K | $114.8M | $124.77M |
| 2023-06-30 | $1.27 | 23.73M | $30.14M | $15.16M | $52.3M | $67.27M |
| 2023-03-31 | $1.40 | 23.67M | $33.14M | $35.46M | $52.9M | $50.58M |
| 2022-12-31 | $3.75 | 23.74M | $89.02M | $60.65M | $51.19M | $79.55M |
| 2022-09-30 | $4.87 | 23.71M | $115.47M | $79.73M | $50.29M | $86.03M |
| 2022-06-30 | $9.32 | 23.12M | $215.51M | $97.83M | $50.27M | $167.95M |
| 2022-03-31 | $6.37 | 23.05M | $146.84M | $129.84M | $49.7M | $66.7M |
| 2021-12-31 | $8.63 | 23.07M | $199.07M | $88.21M | $29.45M | $140.31M |
| 2021-09-30 | $12.18 | 20.15M | $245.44M | $111.29M | $29.28M | $163.44M |
| 2021-06-30 | $8.85 | 14.12M | $124.96M | $60.95M | $8.86M | $72.87M |
| 2021-03-31 | $15.00 | 19.41M | $291.22M | $4.47M | $17M | $303.75M |
| 2020-12-31 | $15.00 | 13.14M | $197.08M | $7.1M | $8.41M | $198.4M |